Ville Männistö

4.6k total citations · 2 hit papers
60 papers, 2.0k citations indexed

About

Ville Männistö is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Ville Männistö has authored 60 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Epidemiology, 17 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Physiology. Recurrent topics in Ville Männistö's work include Liver Disease Diagnosis and Treatment (51 papers), Diet, Metabolism, and Disease (16 papers) and Alcohol Consumption and Health Effects (13 papers). Ville Männistö is often cited by papers focused on Liver Disease Diagnosis and Treatment (51 papers), Diet, Metabolism, and Disease (16 papers) and Alcohol Consumption and Health Effects (13 papers). Ville Männistö collaborates with scholars based in Finland, Sweden and United States. Ville Männistö's co-authors include Jussi Pihlajamäki, Fredrik Åberg, Pirjo Käkelä, Vesa Kärjä, Dorota Kamińska, Vanessa D. de Mello, Carlos J. Pirola, Christopher D. Byrne, Silvia Sookoian and Stefano Romeo and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Ville Männistö

58 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease

2022 160 citations Fredrik Åberg, Ville Männistö et al. Journal of Hepatology profile →
Alcohol-associated liver disease—Global epidemiology

2024 44 citations Fredrik Åberg, Z. Gordon Jiang et al. Hepatology profile →

Peers

Countries citing papers authored by Ville Männistö

Since Specialization

Citations

This map shows the geographic impact of Ville Männistö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ville Männistö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ville Männistö more than expected).

Fields of papers citing papers by Ville Männistö

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ville Männistö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ville Männistö. The network helps show where Ville Männistö may publish in the future.

Co-authorship network of co-authors of Ville Männistö

This figure shows the co-authorship network connecting the top 25 collaborators of Ville Männistö. A scholar is included among the top collaborators of Ville Männistö based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ville Männistö. Ville Männistö is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolic Dysfunction-associated Steatotic Liver Disease Alters Fatty Acid Profiles in the Liver and Adipose Tissue 2025 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Kirsi A. Virtanen, Vesa Kärjä, Ursula Schwab, Dorota Kamińska, Pirjo Käkelä, Jussi Pihlajamäki, Ville Männistö	1
2	An abdominal obesity missense variant in the adipocyte thermogenesis gene TBX15 is implicated in adaptation to cold in Finns 2024 ·The American Journal of Human Genetics ·(unknown), Asha Kar, (unknown), Marcus Alvarez, (unknown), Uma Thanigai Arasu, Dorota Kamińska, Ville Männistö, Sini Heinonen, Birgitta W. van der Kolk, (unknown), Tuure Saarinen, Anne Juuti, Jussi Pihlajamäki, Minna U. Kaikkonen, Markku Laakso, Kirsi H. Pietiläinen, Päivi Pajukanta	0
3	Metabolic signatures of metabolic dysfunction-associated steatotic liver disease in severely obese patients 2024 ·Digestive and Liver Disease ·Ambrin Farizah Babu, (unknown), Vesa Kärjä, (unknown), Marko Lehtonen, Kati Hanhineva, Jussi Pihlajamäki, Ville Männistö	5
4	Alcohol-associated liver disease—Global epidemiology breakdown → 2024 ·Hepatology ·Fredrik Åberg, Z. Gordon Jiang, Helena Cortez‐Pinto, Ville Männistö	44
5	m6A mRNA methylation in brown fat regulates systemic insulin sensitivity via an inter-organ prostaglandin signaling axis independent of UCP1 2024 ·Cell Metabolism ·Ling Xiao, Dario F. De Jesus, (unknown), (unknown), Jiang Hu, (unknown), Tadataka Tsuji, Cheryl Cero, Ville Männistö, (unknown), Siying Wei, (unknown), Matthias Blüher, Aaron M. Cypess, Jussi Pihlajamäki, Yu‐Hua Tseng, Chuan He, Rohit Kulkarni	10
6	Liver saturated fat content associates with hepatic DNA methylation in obese individuals 2023 ·Clinical Epigenetics ·(unknown), Alexander Perfilyev, Ville Männistö, J. Arvid Ågren, Emma Nilsson, Pirjo Käkelä, Charlotte Ling, Vanessa D. de Mello, Jussi Pihlajamäki	13
7	Gut ecological networks reveal associations between bacteria, exercise, and clinical profile in non-alcoholic fatty liver disease patients 2023 ·mSystems ·(unknown), (unknown), (unknown), Ville Männistö, (unknown), (unknown), Kai Savonen, Hani El‐Nezami, Ursula Schwab, Gianni Panagiotou	7
8	Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease 2023 ·EBioMedicine ·(unknown), Marcus Alvarez, Uma Thanigai Arasu, Ilakya Selvarajan, (unknown), David Z. Pan, Zong Miao, Sankha Subhra Das, Dorota Kamińska, Tiit Örd, Jihane N. Benhammou, Martin Wabitsch, Joseph R. Pisegna, Ville Männistö, Kirsi H. Pietiläinen, Markku Laakso, Janet S. Sinsheimer, Minna U. Kaikkonen, Jussi Pihlajamäki, Päivi Pajukanta	14
9	Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease 2023 ·Metabolites ·Lilian Fernandes Silva, Jagadish Vangipurapu, (unknown), Ville Männistö, Markku Laakso	5
10	Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease 2022 ·Nutrients ·(unknown), Vanessa D. de Mello, Ville Männistö, Jaana Lindström, Jaakko Tuomilehto, Jussi Pihlajamäki, Matti Uusitupa	40
11	Attribution of diabetes to the development of severe liver disease in the general population 2022 ·Liver International ·(unknown), Ville Männistö, Veikko Salomaa, Annie Britton, Antti Jula, Satu Männistö, Annamari Lundqvist, Markus Perola, Fredrik Åberg	2
12	Low serum vitamin D level associated with incident advanced liver disease in the general population – a prospective study 2021 ·Scandinavian Journal of Gastroenterology ·Ville Männistö, Tuija Jääskeläinen, Martti Färkkilâ, Antti Jula, Satu Männistö, Annamari Lundqvist, Tanja Zeller, Stefan Blankenberg, Veikko Salomaa, Markus Perola, Fredrik Åberg	4
13	Links between gut microbiome composition and fatty liver disease in a large population sample 2021 ·Gut Microbes ·Matti O. Ruuskanen, Fredrik Åberg, Ville Männistö, Aki S. Havulinna, Guillaume Méric, Yang Liu, Rohit Loomba, Yoshiki Vázquez‐Baeza, Anupriya Tripathi, Liisa Valsta, Michael Inouye, Pekka Jousilahti, Veikko Salomaa, Mohit Jain, Rob Knight, Leo Lahti, Teemu Niiranen	53
14	Incidence of liver‐related morbidity and mortality in a population cohort of non‐alcoholic fatty liver disease 2021 ·Liver International ·Ville Männistö, Veikko Salomaa, Martti Färkkilâ, Antti Jula, Satu Männistö, Iris Erlund, Jouko Sundvall, Annamari Lundqvist, Markus Perola, Fredrik Åberg	19
15	Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis 2021 ·Nutrients ·(unknown), (unknown), Maija Vaittinen, Dorota Kamińska, Ville Männistö, Vesa Kärjä, Marjo Tuomainen, Kati Hanhineva, Stefano Romeo, Päivi Pajukanta, Jussi Pihlajamäki, Vanessa D. de Mello	53
16	Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease 2021 ·Journal of Hepatology ·Panu K. Luukkonen, S. U. Qadri, (unknown), Kimmo Porthan, Ville Männistö, Henna Sammalkorpi, Anne Penttilä, Antti Hakkarainen, Tiina E. Lehtimäki, Melania Gaggini, Amalia Gastaldelli, Mika Ala‐Korpela, Marju Orho‐Melander, Johanna Arola, Anne Juuti, Jussi Pihlajamäki, Leanne Hodson, Hannele Yki‐Järvinen	121
17	Genetic variants in the MTHFR are not associated with fatty liver disease 2020 ·Liver International ·Antonio De Vincentis, Rosellina Margherita Mancina, Jussi Pihlajamäki, Ville Männistö, Salvatore Petta, Paola Dongiovanni, Anna Ludovica Fracanzani, Luca Valenti, Federica Tavaglione, Stefano Romeo, Umberto Vespasiani‐Gentilucci	7
18	Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice 2020 ·Journal of Clinical Investigation ·Dario F. De Jesus, Kazuki Orime, Dorota Kamińska, Tomohiko Kimura, Giorgio Basile, Chih‐Hao Wang, Larissa Haertle, (unknown), Natalie K. Brown, Jiang Hu, Ville Männistö, Amélia M. Silva, Ercument Dirice, Yu‐Hua Tseng, Thomas Haaf, Jussi Pihlajamäki, Rohit Kulkarni	45
19	Total liver phosphatidylcholine content associates with non‐alcoholic steatohepatitis and glycine N‐methyltransferase expression 2019 ·Liver International ·Ville Männistö, Dorota Kamińska, Vesa Kärjä, Mika Tiainen, Vanessa D. de Mello, Kati Hanhineva, Pasi Soininen, Mika Ala‐Korpela, Jussi Pihlajamäki	20
20	Fatty liver - so what? 2018 ·PubMed ·Ville Männistö, Jussi Pihlajamäki	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact